On Monday, October 27, 2025, CollPlant Biotechnologies announced the launch of a new U.S. logistics center that will serve as a cGMP‑compliant storage and distribution hub for its rhCollagen and BioInk product lines in the United States and Canada. The facility, scheduled to become operational this quarter, will provide a clinical supply depot and support the company’s growing customer base across North America.
The new center features state‑of‑the‑art infrastructure, including controlled storage environments, a cloud‑based temperature monitoring system, advanced emergency backup capabilities, AI‑powered security, and remote inventory management. These capabilities are designed to ensure reliable, efficient, and secure distribution that meets the stringent quality and regulatory expectations of CollPlant’s partners and customers.
CEO Yehiel Tal emphasized that the establishment of the U.S. logistics center demonstrates CollPlant’s long‑term commitment to the North American market and represents an important milestone in advancing regenerative medicine products based on its rhCollagen technology. The center is expected to increase efficiency, reduce shipping time, and enable the company to rapidly support customer needs and scale with market demand.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.